Atlas Trials

A Biopharmaceutics Study to Assess the Pharmacokinetics of Single Oral and IV Doses of Olorofim

Clinical trial NCT04207957 · COMPLETED

Trial details

NCT number
NCT04207957
Sponsor
F2G Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2019-12-05
Primary completion
2020-09-15
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.